Back to Screener

Industrials

Nordicus Partners Corporation(NORD)

Live Price

Offline

$3.75

-0.53% today

1Y Change

+81.50%

Window

Jun 26, 2025 โ†’ Jun 17, 2026

Market Cap
$70.00M
Revenue Growth
+100.0%
EPS Growth
-966.7%
Dividend Yield
0.0%

Coverage: 245 bars ยท Jun 26, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Nordicus Partners Corporation (NORD) is a Industrials stock with a market cap of $70.00M and listed on OTC. The stock last traded around $3.75 and up 81.5% across the available one-year price window (Jun 26, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of +100.0%, EPS growth of -966.7%, a dividend yield of 0.0%. What stands out right now is revenue +100.0%, EPS -966.7%, free cash flow -396.1% with operating margin 0.0% and ROIC -5.4%. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NORD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Above sector median

+100.0% vs +6.8% peer median

Operating Margin

Below sector median

0.0% vs +16.9% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on Feb 13, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at +100.0% and EPS is at -966.7%, with operating margin around 0.0%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -2.3% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
Feb 13, 2026
โ€”+0.0%-4.8%-11.0%
2025
Nov 14, 2025
โ€”+0.0%-2.0%-3.1%
2023
Dec 31, 2023
โ€”+0.0%+0.0%+7.5%

Benchmark Edge

NORD vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NORD

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NORD Max Drawdown

-67.83%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NORD and SPY.

Calendar-year return history is still loading or unavailable.
Nordicus Partners Corporation logo

Company Overview

Nordicus Partners Corporation

Other OTC

Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health. It also provides corporate finance activities, including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.

Leadership
Henrik Rouf
IPO Date
Jun 12, 1996
Employees
15
Street Address
280 South Beverly Dr
Mailing
Beverly Hills, CA, 90212
Region
Beverly Hills, CA, US
Reporting Currency
USD
Investor Line
310 666 0750
Last Updated
May 2, 2026
CIK: 0001011060ISIN: US28265K3041CUSIP: 28265K304
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
โ€”
Price/Book
1.1

Growth

Revenue
+100.0%
EPS
-966.7%
Free Cash Flow
-396.1%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-7.2%
ROIC
-5.4%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.71

Earnings Reports

๐Ÿ“… Last reportedFeb 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Feb 13, 26
-0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 25
-0.08
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 23
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 23
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 23
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 23
-1.43
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Feb 14, 23
-0.15
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 22
-0.01
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 26, 22
-0.89
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 22
-0.07
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Dec 31, 21
-0.04
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 30, 21
-0.26
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Sep 13, 21
-0.04
Est โ€”
โ€”
-4.0B
Est โ€”
โ€”
โ€”
Mar 31, 21
-0.18
Est โ€”
โ€”
-1M
Est โ€”
โ€”
โ€”
Dec 31, 20
-0.09
Est โ€”
โ€”
808.0B
Est โ€”
โ€”
โ€”
Sep 30, 20
-0.12
Est โ€”
โ€”
763.0B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.